National Cancer Center

Gyeonggi-do, Ilsandong-gu 10408

0 studies enrolling now · 1 studies all time

What they study most

HER2-positive Advanced Solid Tumor

Studies at this site

• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now